Firefly Neuroscience Says TMS Center Customer Clinical Assessments Using Evoke Platform Rose 291% Year-Over-Year
Share
Why It Matters
Firefly's tool for helping doctors check if brain-zapping therapy is working saw way more customers using it—nearly three times more than last year. When a company's product gets used a lot more, it can mean the product is helping people and the business might be growing.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.